Home
|
Inbox
|
Search
|
Speaker
Susanne Stowasser
M.D.
Boehringer Ingelheim Pharma GmbH & Co. KG
Session(s)
- Gastrointestinal Adverse Events with Nintedanib with Add-On Pirfenidone in Patients with I...
Sunday, May 20 11:15 AM - 1:00 PM - Impact of Lung Function Decline on Health-Related Quality of Life in Patients with Idiopat...
Sunday, May 20 11:15 AM - 1:00 PM - INSTAGE: A Randomized Trial of Nintedanib Plus Sildenafil Versus Nintedanib Alone in Patie...
Sunday, May 20 11:15 AM - 1:00 PM - Investigating the Effect of Nintedanib on Changes in Biomarkers of ECM Turnover in Patient...
Sunday, May 20 11:15 AM - 1:00 PM - Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis (IPF)...
Sunday, May 20 11:15 AM - 1:00 PM - Predicted Versus Observed Mortality in Clinical Trials of Nintedanib in Idiopathic Pulmona...
Sunday, May 20 2:15 PM - 4:15 PM - Predicting Mortality in Idiopathic Pulmonary Fibrosis (IPF) Patients Treated with Nintedan...
Sunday, May 20 2:15 PM - 4:15 PM - No Relevant Pharmacokinetic Interaction Between Nintedanib and Pirfenidone in Patients wit...
Wednesday, May 23 1:30 PM - 3:30 PM
|
Home
|
Inbox
|
Search
|